1. Therapeutic carrier based on solanesol and hyaluronate for synergistic tumor treatment
- Author
-
Mengying, Zhang, Huimin, Yu, Jinglu, Hu, Zhengyu, Zhao, Lei, Liu, Gaomin, Yang, Tingli, Wang, Guang, Han, and Shiyong, Song
- Subjects
Drug Carriers ,Drug Liberation ,Drug Delivery Systems ,Doxorubicin ,Terpenes ,Structural Biology ,Neoplasms ,Humans ,Nanoparticles ,General Medicine ,Hyaluronic Acid ,Molecular Biology ,Biochemistry - Abstract
The administration of nanodrugs can lead to metabolism related systemic toxicity due to the use of inert carriers in large quantities. Carrier materials that offer therapeutic effects are therefore a promising means of addressing this limitation. Herein, a hyaluronate-based nanocarrier was prepared from hyaluronic acid (HA) and solanesol. Solanesyl thiosalicylate (STS) derived from solanesol has certain antitumor effects and was used to modify HA. The conjugate (HA-STS) self-assembled into nanoparticles acting as a drug carrier. The synthesis of the conjugates was confirmed by
- Published
- 2022